Interrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammation

Advances in Experimental Medicine and Biology

Volumn 660, Issue , 2010, Pages 5-18

  Camps, Jordi ^a   Marsillach, Judit ^a   Rull, Anna ^a   Alonso Villaverde, Carlos ^a   Joven, Jorge ^a  

^a NONE

Author keywords

Chemoattractant protein 1; Inflammation; Liver impairment; Monocyte; Oxidative stress; Paraoxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; FREE RADICAL; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR;

ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; CHRONIC LIVER DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEPATITIS; HEPATITIS C; HUMAN; INFLAMMATORY INFILTRATE; LIPID PEROXIDATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER PROTECTION; LIVER TOXICITY; MALIGNANT TRANSFORMATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 79955968062     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-350-3_2     Document Type: Review

References (73)

1. Abdallah MY, Ahmad IM, Spitz DR et al. (2005) Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 76:489-497 (Pubitemid 40943258)
2. Afford SC, Fischer NC, Neil DAH et al. (1998) Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol 186:82-89 (Pubitemid 28407492)
3. Albano E (2006) Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 65:278-290 (Pubitemid 46323842)
4. Albano E (2008) Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 29:9-16 (Pubitemid 351312214)
5. Aleffi S, Petrai I, Bertolani C et al. (2005) Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42:1339-1348 (Pubitemid 43260036)
6. Aviram M, Rosenblat M, Billecke S et al. (1999) Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Rad Biol Med 26: 892-904 (Pubitemid 29198362)
7. Aviram M, Hardak E, Vaya J et al. (2000) Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions. PON1 esterase and peroxidase-like activities. Circulation 101:2510-2517 (Pubitemid 30366256)
8. Batey RG, Cao Q, Gould B (2002) Lymphocyte-mediated liver injury in alcohol-related hepatitis. Alcohol 27:37-41 (Pubitemid 34626482)
9. Birjmohun RS, Van Leuven SI, Levels JHM et al. (2007) High-density lipoprotein attenuates inflammation and coagulation on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol 27:1153-1158 (Pubitemid 46641971)
10. Burlina A, Galzigna L (1974) Serum arylesterase isoenzymes in chronic hepatitis. Clin Biochem 7:202-205
11. Burlina A, Michielin E, Galzigna L (1977) Characteristics and behaviour of arylesterase in human serum and liver. Eur J Clin Inves 7:17-20 (Pubitemid 8299886)
12. Cabré M, Ferré N, Folch J et al. (1999) Inhibition of hepatic cell nuclear DNA fragmentation by zinc in carbon tetrachloride-treated rats. J Hepatol 31:228-234 (Pubitemid 29349747)
13. Calabresi L, Gomaraschi M, Vilia B et al. (2002) Elevated soluble adhesion molecules in subjects with low HDL-cholesterol. Arterioscler Thromb Vasc Biol 22:656-661 (Pubitemid 34408749)
14. Camps J, Marsillach J, Joven J (2007) Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment. Clin Chim Acta 386:114-115 (Pubitemid 47422321)
15. Chittury S, Farrell GC (2001) Ethiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21:27-41
16. Choi J, Lee KJ, Zheng Y et al. (2004) Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39:81-89 (Pubitemid 38461470)
17. Choi J, Ou JHJ (2006) Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290:G847-G851
18. Clay MA, Pyle DH, Rye KA et al. (2001) Time sequence of inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins. Atherosclerosis 157:23-29 (Pubitemid 32539350)
19. Cockerill GW, Rye KA, Gamble JR et al. (1995) High density lipoproteins inhibit cytokine induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 15: 1987-1994
20. Costa LG, Vitalone A, Cole TB et al. (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550
21. Crabb DW, Liangpunsakul S (2006) Alcohol and lipid metabolism. J Gastroenterol Hepatol 21:S56-S60 (Pubitemid 44266552)
22. Day CP (2006) Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 26:1021-1028 (Pubitemid 44541742)
23. Deakin S, Leviev I, Gomaraschi M et al. (2002) Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J Biol Chem 277:4301-4308 (Pubitemid 34968695)
24. Deakin S, Leviev I, Brulhart-Meynet MC et al. (2003) Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant rele for polymorphic position -107, implicating the Sp1 transcription factor. Biochem J 372:643-649 (Pubitemid 36723911)
25. Devalaraja MN, McClain CJ,Barve S et al. (1999) Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine 11:875-881 (Pubitemid 29537537)
26. Ferré N, Camps J, Cabré M et al. (2001) Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. Metabolism 50:997-1000 (Pubitemid 32904153)
27. Ferré N, Camps J, Prats E et al. (2002) Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem 48:261-268 (Pubitemid 34107262)
28. Ferré N, Marsillach J, Camps J et al. (2005) Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection. Clin Chim Acta 361:206-210 (Pubitemid 41382625)
29. Ferré N, Marsillach J, Camps J et al. (2006). Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J Hepatol 45:51-59 (Pubitemid 43850613)
30. Fisher NC, Neil DAH, Williams A et al. (1999) Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1and macrophage inflammatory protein 1? in alcoholic liver disease. Gut 45:426-430
31. Forman HJ, Torres M, Fukuto J (2003) Signal transduction by reactive oxygen and nitrogen species: pathways and chemical principles. Kluwer Academic, Boston
32. Fromenty B, Grimbert S, Mansouri A et al. (1995) Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 108:193-200
33. F?rnsinn C, Willson TM, Brunmair B (2007) Peroxisome proliferator- activated receptor-?, a regulator of oxidative capacity, fuel switching and cholesterol transport. Diabetologia 50:8-17 (Pubitemid 46035846)
34. James RW, Deakin SP (2004) The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Rad Biol Med 37:1986-1994 (Pubitemid 39491318)
35. Jiang Y, Beller DI, Frendl G et al. (1992) Monocyte chemoattractant protein-1regulates adhesion molecule expression and cytokine production in human monocytes J Immunol 148:2423-2428
36. Kawai H, Sakamoto F, Inoue Y (1990) Improved specific assay for serum arylesterase using a water-soluble substrate. Clin Chim Acta 188:177-182 (Pubitemid 20150123)
37. Kharbanda KK, McVicker DL, Zetterman RK et al. (1995) Ethanol consumption reduces the proteolytic capacity and protease activities of hepatic lysosomes. Biochem Biophys Acta 1245:421-429
38. Kilic SS, Aydin S, Kilic N et al. (2005) Serum arylesterase and paraoxonase activity in patients with chronic hepatitis. World J Gastroenterol 11:7351-7354 (Pubitemid 43137689)
39. Kleiner DE, Brunt EM, Natta MV et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321 (Pubitemid 40770284)
40. Mackness B, Hine D, Liu Y et al. (2004) Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem Biophys Res Commun 318:680-683 (Pubitemid 38624207)
41. Mahmood S, Kawanaka M, Kamei A et al. (2004) Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. Antioxid Redox Signal 6:19-24 (Pubitemid 38063973)
42. Marsillach J, Bertran N, Camps J et al. (2005) The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease. Clin Biochem 38:1138-1140 (Pubitemid 41797756)
43. Marsillach J, Ferré N, Vila MC et al. (2007) Serum paraoxonase-1 in chronic alcoholics: Relationship with liver disease. Clin Biochem 40:645-650 (Pubitemid 46839097)
44. Marsillach J, Aragonès G, Beltrán R et al. (2008) The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem doi:10. 1016/j. clinbiochem. 2008. 09. 120
45. Marsillach J, Camps J, Ferr? N et al. (2009) Paraoxonase-1 is related to inflammation, fibrosis and PPAR? in experimental liver disease. BMC Gastroenterol 9:3
46. Mottaran E, Stewart SF, Rolla R et al. (2002) Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Rad Biol Med 32:38-48
47. Nanji AA (2004) Role of different dietary fatty acids in the pathogenesis of experimental alcoholic liver disease. Alcohol 34:21-25
48. Navab M, Imes SS. Hama SY et al. (1991) Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88:2039-2046
49. Navab M, Hama SY, Cooke CJ et al. (2000a) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lip Res 41:1481-1484
50. Navab M, Hama SY, Anantharamaiah GM et al. (2000b) Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lip Res 41:1485-1508
51. Navab M, Berliner JA, Subbanagounder G et al. (2001) HDL and the inflammatory response induced by LDL-derived oxidised phospholipids. Arterioscler Thromb Vasc Biol 21:481-488 (Pubitemid 32323377)
52. Navab M, Ananthramaiah GM, Reddy ST et al. (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lip Res 45:993-1007. (Pubitemid 38679495)
53. Negre-Salvayre A, Dousset N, Ferretti G et al. (2006) Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells. Free Rad Biol Med 41:1031-1040 (Pubitemid 44348872)
54. Nieto N (2007) Ethanol and fish oil induce NFkB transactivation of the collagen a2(1) promoter through lipid peroxidation-driven activation of PKC-PI3K-Akt pathway. Hepatology 45: 1433-1445 (Pubitemid 46918327)
55. Nofer JR, Kehrel B, Fobker M et al. (2002) HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161:1-16 (Pubitemid 34214816)
56. Pan M, Cederbaum AI, Zhang YL et al. (2004) Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest 113:1277-1287 (Pubitemid 39069927)
57. Parola M, Bellomo G, Robino G et al. (1999) 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxidant Redox Signaling 1:255-284 (Pubitemid 129622798)
58. Pesant M, Sueur S, Dutartre P et al. (2006) Peroxisome proliferator-activated receptor ? (PPAR?) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc Res 69:440-449 (Pubitemid 43098800)
59. Pessayre D, Fromenty B (2005) NASH a mitochondrial disease. J Hepatol 42:928-940
60. Rao MN, Marmillot P, Gong M et al. (2003) Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 52:1287-1294 (Pubitemid 37351096)
61. Simpson KJ, Henderson NC, Bone-Larson CL et al. (2003) Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clin Sci (Lond) 104:47-63 (Pubitemid 36249923)
62. Solís Herruzo JA, García Ruíz I, Pérez Carreras M et al. (2006) Non-alcoholic fatty liver disease. from insulin resistance to mitochondrial dysfunction. Rev Esp Enferm Dig (Madrid) 98: 844-874 (Pubitemid 350259114)
63. Sugano M, Tsuchida K, Makino N (2000) High-density lipoproteins protect endothelial cells from tumor necrosis factor-a-induced apoptosis. Biochem Biophys Res Commun 272: 872-876 (Pubitemid 30420728)
64. Tamura Y, Sugimoto M, Muruyama T et al. (2008) Inhibition of CCR2 ameliorates insulin resistance and hepatic steatosis in db/db mice. Arterioscler Thromb Vasc Biol doi:10.1161/ATVBAHA. 108. 168633
65. Tardif KD, Waris G, Siddiqui A (2005) Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 13:159-163 (Pubitemid 40463317)
66. Thiele GM, Freeman TK, Klassen LW (2004) Immunological mechanisms of alcoholic liver disease. Semin Liver Dis 24:273-287 (Pubitemid 39167685)
67. Thoren F, Romero A, Lindh M et al. (2004) A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. J Leukoc Biol 76:1180-1186 (Pubitemid 39602954)
68. Tous M, Ferré N, Rull A et al (2006) Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice Biochem Biophys Res Commun 340:1078-1084 (Pubitemid 43083388)
69. Tsukamoto H, Lu SC (2001) Current concepts in the pathogenesis of alcoholic liver injury. FASEB J 15:1335-1349 (Pubitemid 32531812)
70. Tsuruta S, Nakamuta M, Enjoji M et al. (2004) Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats. Int J Mol Med 14: 837-842
71. Younossi ZM, Diehl AM, Ong JP (2002) Nonalcoholic fatty liver disease: An agenda for clinical research. Hepatology 35:746-752 (Pubitemid 34258367)
72. Xu GY, Lv GC, Chen Y et al. (2005) Monitoring the level of serum paraoxonase 1 activity in liver transplantation patients. Hepatobiliary Pancreat Dis Int 4:178-181 (Pubitemid 40790161)
73. Zamara E, Novo E, Marra F et al. (2004) 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J Hepatol 40:60-68 (Pubitemid 38067269)